30 research outputs found
Neurotransmitter release and its presynaptic modulation in the rat hippocampus after selective damage to cholinergic or/and serotonergic afferents
Male Long-Evans rats sustained injections of 5,7-dihydroxytryptamine (5,7-DHT) into the fimbria-fornix and the cingular bundle or/and intraseptal injections of 192 IgG-saporin to induce serotonergic or/and cholinergic hippocampal denervations; Sham-operated rats served as controls. Four to ten weeks after lesioning, we measured (i). the electrically evoked release of acetylcholine ([3H]ACh), noradrenaline ([3H]NA) and serotonin ([3H]5-HT) in hippocampal slices in the presence of drugs acting on auto- or heteroreceptors, (ii). the nicotine-evoked release of NA and (iii). the choline acetyltransferase (ChAT) activity and the concentration of monoamines in homogenates. Saporin lesions reduced the accumulation of [3H]choline, the release of [3H]ACh and the ChAT activity, but increased the concentration of NA and facilitated the release of [3H]NA evoked by nicotine. 5,7-DHT lesions reduced the accumulation and the release of [3H]5-HT, the concentration of 5-HT, and also facilitated the release of [3H]NA evoked by nicotine. Accumulation and electrically evoked release of [3H]NA were not altered by either lesion. The combination of both toxins resulted in an addition of their particular effects. The 5-HT(1B) receptor agonist, CP 93129, and the muscarinic agonist, oxotremorine, reduced the release of [3H]ACh in control and 5,7-DHT-lesioned rats; in rats injected with saporin, their effects could not be measured reliably. CP 93129 and the alpha(2)-adrenoceptor agonist, UK 14304, reduced the release of [3H]5-HT in all groups by about 65%.
IN CONCLUSION:
(i). selective neurotoxins can be combined to enable controlled and selective damage of hippocampal transmitter systems; (ii). 5-HT exerts an inhibitory influence on the nicotine-evoked release of NA, but partial serotonergic lesions do not influence the release of ACh at a presynaptic level and (iii). presynaptic modulatory mechanisms involving auto- and heteroreceptors may be conserved on fibres spared by the lesions
Spleen-Resident CD4+ and CD4â CD8αâ Dendritic Cell Subsets Differ in Their Ability to Prime Invariant Natural Killer T Lymphocytes
One important function of conventional dendritic cells (cDC) is their high capacity to capture, process and present Ag to T lymphocytes. Mouse splenic cDC subtypes, including CD8α+ and CD8αâ cDC, are not identical in their Ag presenting and T cell priming functions. Surprisingly, few studies have reported functional differences between CD4â and CD4+ CD8αâ cDC subsets. We show that, when loaded in vitro with OVA peptide or whole protein, and in steady-state conditions, splenic CD4â and CD4+ cDC are equivalent in their capacity to prime and direct CD4+ and CD8+ T cell differentiation. In contrast, in response to α-galactosylceramide (α-GalCer), CD4â and CD4+ cDC differentially activate invariant Natural Killer T (iNKT) cells, a population of lipid-reactive non-conventional T lymphocytes. Both cDC subsets equally take up α-GalCer in vitro and in vivo to stimulate the iNKT hybridoma DN32.D3, the activation of which depends solely on TCR triggering. On the other hand, and relative to their CD4+ counterparts, CD4â cDC more efficiently stimulate primary iNKT cells, a phenomenon likely due to differential production of co-factors (including IL-12) by cDC. Our data reveal a novel functional difference between splenic CD4+ and CD4â cDC subsets that may be important in immune responses
Understanding the Role of Electronic Effects in CO on the Pt-Sn Alloy Surface via Band Structure Measurements
Using angle-resolved photoemission spectroscopy, we show direct evidence for charge transfer between adsorbed molecules and metal substrates, i.e., chemisorption of CO on Pt(111) and Pt-Sn/Pt(111) 2 x 2 surfaces. The observed band structures show a unique signature of charge transfer as CO atoms are adsorbed, revealing the roles of specific orbital characters participating in the chemisorption process. As the coverage of CO increases, the degree of charge transfer between CO and Pt shows a clear difference to that of Pt-Sn. With comparison to density functional theory calculation results, the observed distinct features in the band structure are interpreted as back-donation bonding states formed between the Pt molecular orbital and the 2 pi orbital of CO. Furthermore, the change in the surface charge concentration, measured from the Fermi surface area, shows that the Pt surface has a larger charge concentration change than the Pt-Sn surface upon CO adsorption. The differences between Pt and Pt-Sn surfaces are due to the effect of Pt-Sn intermetallic bonding on the interaction of CO with the surface
Novel Blood Pressure Locus and Gene Discovery Using Genome-Wide Association Study and Expression Data Sets From Blood and the Kidney.
Elevated blood pressure is a major risk factor for cardiovascular disease and has a substantial genetic contribution. Genetic variation influencing blood pressure has the potential to identify new pharmacological targets for the treatment of hypertension. To discover additional novel blood pressure loci, we used 1000 Genomes Project-based imputation in 150 134 European ancestry individuals and sought significant evidence for independent replication in a further 228 245 individuals. We report 6 new signals of association in or near HSPB7, TNXB, LRP12, LOC283335, SEPT9, and AKT2, and provide new replication evidence for a further 2 signals in EBF2 and NFKBIA Combining large whole-blood gene expression resources totaling 12 607 individuals, we investigated all novel and previously reported signals and identified 48 genes with evidence for involvement in blood pressure regulation that are significant in multiple resources. Three novel kidney-specific signals were also detected. These robustly implicated genes may provide new leads for therapeutic innovation
Large expert-curated database for benchmarking document similarity detection in biomedical literature search
Document recommendation systems for locating relevant literature have mostly relied on methods developed a decade ago. This is largely due to the lack of a large offline gold-standard benchmark of relevant documents that cover a variety of research fields such that newly developed literature search techniques can be compared, improved and translated into practice. To overcome this bottleneck, we have established the RElevant LIterature SearcH consortium consisting of more than 1500 scientists from 84 countries, who have collectively annotated the relevance of over 180 000 PubMed-listed articles with regard to their respective seed (input) article/s. The majority of annotations were contributed by highly experienced, original authors of the seed articles. The collected data cover 76% of all unique PubMed Medical Subject Headings descriptors. No systematic biases were observed across different experience levels, research fields or time spent on annotations. More importantly, annotations of the same document pairs contributed by different scientists were highly concordant. We further show that the three representative baseline methods used to generate recommended articles for evaluation (Okapi Best Matching 25, Term Frequency-Inverse Document Frequency and PubMed Related Articles) had similar overall performances. Additionally, we found that these methods each tend to produce distinct collections of recommended articles, suggesting that a hybrid method may be required to completely capture all relevant articles. The established database server located at https://relishdb.ict.griffith.edu.au is freely available for the downloading of annotation data and the blind testing of new methods. We expect that this benchmark will be useful for stimulating the development of new powerful techniques for title and title/abstract-based search engines for relevant articles in biomedical research.Peer reviewe
Synthesis of new ligands of CD1d receptor : applications to anti-tumor vaccination
Lâobjectif de cette thĂšse a Ă©tĂ© dâoptimiser la rĂ©ponse immunitaire anti-tumorale induite par les cellules dendritiques (DC) et les cellules iNKTs, en rĂ©ponse Ă la prise en charge du KRN7000 (a-galactosyl-cĂ©ramide) par la molĂ©cule CD1d situĂ©e sur les DCs. Le premier axe de travail visait Ă synthĂ©tiser de nouveaux analogues du KRN7000, en fonctionnalisant la position C6 du sucre et en greffant un groupement phĂ©nyl sur lâune des chaĂźnes grasses. Les Ă©tudes in vitro ont montrĂ© que les modifications apportĂ©es par rapport au KRN7000 nâont pas altĂ©rĂ© la prise en charge des molĂ©cules obtenues par les DCs. Dans tous les cas, une sĂ©crĂ©tion de cytokines a pu ĂȘtre observĂ©e. Des Ă©tudes complĂ©mentaires visant Ă dĂ©crire le profil cytokinique in vivo sont en cours. Le second axe a consistĂ© en la mise au point dâune stratĂ©gie de vectorisation du KRN7000 afin de favoriser sa prĂ©sentation aux DCs, en lâassociant Ă des molĂ©cules dâintĂ©rĂȘt comme un peptide spĂ©cifique dâune tumeur, une molĂ©cule de ciblage des DCs ou des ligands des TLRs. Dans les conditions utilisĂ©es, le phĂ©nomĂšne dâanergie induit classiquement par lâadministration rĂ©pĂ©tĂ©e du KRN7000 nâa pas pu ĂȘtre levĂ©. Cependant, nous avons montrĂ© dâune part que le KRN7000 vectorisĂ© dans les liposomes est toujours pris en charge par les cellules dendritiques, et dâautre part quâune rĂ©ponse immunitaire se traduisant par la production de cytokines par les cellules iNKTs est induite.The aim of this project was to optimize the anti-tumor immune response induced by dendritic and iNKTs cells, in response to KRN7000 (a-galactosyl-ceramide), which interacts with CD1d molecule situated on DCs. At first we synthesized new analogues of KRN7000, by functionalizing the C6 position of the carbohydrate moiety and by grafting a phenyl group on one of the fatty chain. In vitro studies indicated that chemical modifications of KRN7000 did not alter its interaction with CD1d. In all cases, cytokine secretion was observed. Further studies are in progress to describe the in vivo cytokine profile. In a second step, we developed liposomal constructs incorporating KRN7000 to optimize its presentation to DCs. Some constructions containing KRN7000 were able to associate a peptide, a targetting molecule of DCs or TLR ligands. Even if the anergy phenomenon induced by repeated administrations of KRN7000 could not be regulated by the use of liposomes, we have shown that encapsulated KRN7000 is still supported by DCs and that an immune response resulting in cytokines secretion by iNKT cells is induced
SynthÚse de nouveaux ligands du récepteur CD1d : applications à la vaccination anti-tumorale
The aim of this project was to optimize the anti-tumor immune response induced by dendritic and iNKTs cells, in response to KRN7000 (a-galactosyl-ceramide), which interacts with CD1d molecule situated on DCs. At first we synthesized new analogues of KRN7000, by functionalizing the C6 position of the carbohydrate moiety and by grafting a phenyl group on one of the fatty chain. In vitro studies indicated that chemical modifications of KRN7000 did not alter its interaction with CD1d. In all cases, cytokine secretion was observed. Further studies are in progress to describe the in vivo cytokine profile. In a second step, we developed liposomal constructs incorporating KRN7000 to optimize its presentation to DCs. Some constructions containing KRN7000 were able to associate a peptide, a targetting molecule of DCs or TLR ligands. Even if the anergy phenomenon induced by repeated administrations of KRN7000 could not be regulated by the use of liposomes, we have shown that encapsulated KRN7000 is still supported by DCs and that an immune response resulting in cytokines secretion by iNKT cells is induced.Lâobjectif de cette thĂšse a Ă©tĂ© dâoptimiser la rĂ©ponse immunitaire anti-tumorale induite par les cellules dendritiques (DC) et les cellules iNKTs, en rĂ©ponse Ă la prise en charge du KRN7000 (a-galactosyl-cĂ©ramide) par la molĂ©cule CD1d situĂ©e sur les DCs. Le premier axe de travail visait Ă synthĂ©tiser de nouveaux analogues du KRN7000, en fonctionnalisant la position C6 du sucre et en greffant un groupement phĂ©nyl sur lâune des chaĂźnes grasses. Les Ă©tudes in vitro ont montrĂ© que les modifications apportĂ©es par rapport au KRN7000 nâont pas altĂ©rĂ© la prise en charge des molĂ©cules obtenues par les DCs. Dans tous les cas, une sĂ©crĂ©tion de cytokines a pu ĂȘtre observĂ©e. Des Ă©tudes complĂ©mentaires visant Ă dĂ©crire le profil cytokinique in vivo sont en cours. Le second axe a consistĂ© en la mise au point dâune stratĂ©gie de vectorisation du KRN7000 afin de favoriser sa prĂ©sentation aux DCs, en lâassociant Ă des molĂ©cules dâintĂ©rĂȘt comme un peptide spĂ©cifique dâune tumeur, une molĂ©cule de ciblage des DCs ou des ligands des TLRs. Dans les conditions utilisĂ©es, le phĂ©nomĂšne dâanergie induit classiquement par lâadministration rĂ©pĂ©tĂ©e du KRN7000 nâa pas pu ĂȘtre levĂ©. Cependant, nous avons montrĂ© dâune part que le KRN7000 vectorisĂ© dans les liposomes est toujours pris en charge par les cellules dendritiques, et dâautre part quâune rĂ©ponse immunitaire se traduisant par la production de cytokines par les cellules iNKTs est induite
Synthesis of new ligands of CD1d receptor : applications to anti-tumor vaccination
Lâobjectif de cette thĂšse a Ă©tĂ© dâoptimiser la rĂ©ponse immunitaire anti-tumorale induite par les cellules dendritiques (DC) et les cellules iNKTs, en rĂ©ponse Ă la prise en charge du KRN7000 (a-galactosyl-cĂ©ramide) par la molĂ©cule CD1d situĂ©e sur les DCs. Le premier axe de travail visait Ă synthĂ©tiser de nouveaux analogues du KRN7000, en fonctionnalisant la position C6 du sucre et en greffant un groupement phĂ©nyl sur lâune des chaĂźnes grasses. Les Ă©tudes in vitro ont montrĂ© que les modifications apportĂ©es par rapport au KRN7000 nâont pas altĂ©rĂ© la prise en charge des molĂ©cules obtenues par les DCs. Dans tous les cas, une sĂ©crĂ©tion de cytokines a pu ĂȘtre observĂ©e. Des Ă©tudes complĂ©mentaires visant Ă dĂ©crire le profil cytokinique in vivo sont en cours. Le second axe a consistĂ© en la mise au point dâune stratĂ©gie de vectorisation du KRN7000 afin de favoriser sa prĂ©sentation aux DCs, en lâassociant Ă des molĂ©cules dâintĂ©rĂȘt comme un peptide spĂ©cifique dâune tumeur, une molĂ©cule de ciblage des DCs ou des ligands des TLRs. Dans les conditions utilisĂ©es, le phĂ©nomĂšne dâanergie induit classiquement par lâadministration rĂ©pĂ©tĂ©e du KRN7000 nâa pas pu ĂȘtre levĂ©. Cependant, nous avons montrĂ© dâune part que le KRN7000 vectorisĂ© dans les liposomes est toujours pris en charge par les cellules dendritiques, et dâautre part quâune rĂ©ponse immunitaire se traduisant par la production de cytokines par les cellules iNKTs est induite.The aim of this project was to optimize the anti-tumor immune response induced by dendritic and iNKTs cells, in response to KRN7000 (a-galactosyl-ceramide), which interacts with CD1d molecule situated on DCs. At first we synthesized new analogues of KRN7000, by functionalizing the C6 position of the carbohydrate moiety and by grafting a phenyl group on one of the fatty chain. In vitro studies indicated that chemical modifications of KRN7000 did not alter its interaction with CD1d. In all cases, cytokine secretion was observed. Further studies are in progress to describe the in vivo cytokine profile. In a second step, we developed liposomal constructs incorporating KRN7000 to optimize its presentation to DCs. Some constructions containing KRN7000 were able to associate a peptide, a targetting molecule of DCs or TLR ligands. Even if the anergy phenomenon induced by repeated administrations of KRN7000 could not be regulated by the use of liposomes, we have shown that encapsulated KRN7000 is still supported by DCs and that an immune response resulting in cytokines secretion by iNKT cells is induced
Systemic allergic reaction and diffuse bone pain after exposure to a preparation of betamethasone
Allergic reactions to corticosteroids are unexpected as they seem to contradict their pharmacodynamic action. Nevertheless, they are not infrequent, with an estimated incidence of up to 4% for cutaneous reactions. Systemic reactions are rarely reported, but their incidence might be underestimated. We report here an unusual allergic reaction to betamethasone presenting with diffuse bone pain, erythema, and bronchoconstriction, which was confirmed by a positive rechallenge in a double-blind procedure. This is the first case report of a systemic reaction to betamethasone confirmed by a positive rechallenge. An impurity in betamethasone diproprionate cannot be excluded. As this substance is frequently used in rheumatologic soft-tissue injections, it is important to recognize this potentially life-threatening side effect
The aqui network: soil moisture sites in the âLes Landesâ forest and graves vineyards (Bordeaux Aquitaine Region, France)
International audienceINRA (National Institute of Agricultural Research) has set up the AQUI network in the Bordeaux-Aquitaine region (southwestern France) in the framework of the SMOS cal/val activities. This network includes sites of in situ measurements which have been equipped with sensors measuring soil moisture (SM) and temperature, at various depths, and the height of the groundwater table. Four sites were installed in the Les Landes forest, which is one of the largest coniferous forests in Europpe, and one site was installed close to vineyard fields of the Bordeaux Graves region. First results of the evaluation of the SM data retrieved from the L-band SMOS and SMAP passive microwave radiometers over the AQUI network are presented. The AQUI network was included in ISMN (International Soil moisture Network) in 2018